SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (UPDATE 2025)
Advanced breast cancer represents a challenge for patients and physicians due to its dynamic genomic changes, which are associated with resistance to treatments. The main goals of treatment in advanced breast cancer are to improve patient quality of life and to increase patient survival. This is achieved using the most appropriate sequence of treatments based on knowledge of the natural history of the disease. In these guidelines (updated in 2025), we summarize current evidence and available therapies for the medical management of advanced breast cancer.
Authors
- Teresa Ramón y Cajal (ORCID: https://orcid.org/0000-0003-3490-3585)
- Sònia Pernas (ORCID: https://orcid.org/0000-0002-1485-5080)
- José Á. García-Sáenz (ORCID: https://orcid.org/0000-0001-6880-0301)
- Isabel Blancas (ORCID: https://orcid.org/0000-0002-5867-6615)
- Isabel Echavarría (ORCID: https://orcid.org/0000-0002-1156-7681)
- Fernando Moreno (ORCID: https://orcid.org/0000-0001-8933-0687)
- Mireia Margelí Vila (ORCID: https://orcid.org/0000-0003-3594-4530)
- Meritxell Bellet Ezquerra
- Nuria Ribelles (ORCID: https://orcid.org/0000-0003-3194-7398)
- Carmen Hinojo Gonzalez
Institutions
- Hebron University (PS)
- Hospital de Sant Pau (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
- Marqués de Valdecilla University Hospital (ES)
- Institut Català d'Oncologia (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Badalona Serveis Assistencials (ES)
- Hospital Clínico Universitario Virgen de la Victoria (ES)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
Publication Details
- Journal
- Clinical & Translational Oncology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1007/s12094-025-04102-w
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sociedad Española de Oncología Médica